Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program

The Defense Health Agency is soliciting quotations from pharmaceutical manufacturers for placement on the Department of War Uniform Formulary (UF) for the Military Health System, including both Uniform Formulary Blanket Purchase Agreements (UF BPA) for Military Treatment Facilities and TRICARE Mail Order Pharmacy pricing, and Uniform Formulary Additional Discount Program (UF ADP) quotes for TRICARE retail network pharmacies. Seven drug classes and newly approved drugs will be reviewed by the Pharmacy and Therapeutics (P&T) Committee at its May 6-7, 2026 meeting, including medications in cardiovascular, skeletal muscle relaxant, antibiotic, electrolyte replacement, and erectile dysfunction categories. Manufacturers must submit complete pricing quotations, including pricing per NDC package size and per unit for both Uniform Formulary and Non-Formulary scenarios, as well as refund information based on Federal Ceiling Prices or Wholesale Acquisition Cost methodologies for the ADP program. The evaluation will be based on relative clinical effectiveness and cost effectiveness of the pharmaceutical agents within their respective therapeutic classes, with the P&T Committee potentially recommending preferential tier status, step therapy requirements, or complete exclusion from the TRICARE pharmacy benefit program. Quotations are due by March 26, 2026, at 12:00 PM CST, with a mandatory pre-quotation teleconference scheduled for March 11, 2026, and manufacturers must submit signed agreements along with an NDC Price List containing all package sizes and strengths.

This solicitation is not restricted by any set-aside designation and does not identify specific incumbent contractors. No specific award value or budget range is disclosed in the solicitation notice; pricing will be determined competitively based on manufacturers' submitted quotations. For BPA agreements, prices must be equal to or lower than FSS, Big 4, and JNC prices, and BPA agreements will remain valid for 180 days and continue until drug class reevaluation or termination, with prices effective in DOD Prime Vendor systems no later than 14 calendar days after contract signing. ADP agreements are contingent on pharmaceutical agents being placed on the UF in no worse than the formulary cost share tier, with refunds calculated quarterly. The place of performance is identified as San Antonio, Texas 78230, where the Defense Health Agency is located.